Aspirin and NS-398 Effects on Colon Cancer Cells
Author Information
Author(s): Ricchi P, Matola T Di, Ruggiero G, Zanzi D, Apicella A, di Palma A, Pensabene M, Pignata S, Zarrilli R, Acquaviva A M
Primary Institution: Dipartimento di Biologia e Patologia Cellulare e Molecolare ‘L. Califano’, Istituto di Endocrinologia ed Oncologia Sperimentale ‘G. Salvatore’ del Consiglio Nazionale delle Ricerche, Università ‘Federico II’, Napoli, Italy
Hypothesis
Do aspirin and NS-398 affect the sensitivity of Caco-2 colon cancer cells to topoisomerase inhibitors?
Conclusion
Aspirin co-treatment reduces anticancer drug-induced apoptosis in Caco-2 cells, while NS-398 has variable effects depending on concentration.
Supporting Evidence
- Aspirin treatment reduces apoptosis in Caco-2 cells when combined with topoisomerase inhibitors.
- NS-398's effects on apoptosis vary with concentration.
- Aspirin increases bcl-2 expression, promoting cell survival.
- Cell cycle analysis shows aspirin affects G0/G1 phase distribution.
- Combination therapy with NSAIDs may alter chemotherapy effectiveness.
Takeaway
Aspirin helps colon cancer cells survive when treated with certain drugs, but NS-398's effects can change based on how much is used.
Methodology
Caco-2 cells were treated with aspirin and NS-398, followed by exposure to topoisomerase inhibitors, and analyzed for apoptosis and cell cycle distribution.
Potential Biases
Potential bias in interpreting the effects of NSAIDs on cancer cell behavior.
Limitations
The study is limited to in vitro conditions and may not fully represent in vivo responses.
Participant Demographics
Caco-2 colon cancer cell line used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website